Summary of the Second International Sentinel Node Conference

O. E. Nieweg; P. J. Tanis; E. J. Rutgers

doi:10.1007/s002590100513

Summary of the Second International Sentinel Node Conference

O. E. Nieweg
, P. J. Tanis
, E. J. Rutgers

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

A personal account is given of the most notable developments in lymphatic mapping that were discussed at the international conference "Sentinel Node 2000", held in December 2000 in Santa Monica. The latest advances in tracers, imaging, instrumentation and radiation are first outlined. Thereafter, techniques, results and controversies with respect to melanoma, breast cancer and other cancers are discussed. It is concluded that lymphatic mapping is quickly gaining momentum. The technique that is best used for lymphatic mapping is well established in melanoma but not in breast cancer. The results of large randomised studies are awaited in both these diseases. Gastrointestinal cancer is the main new focus

Original language	English
Pages (from-to)	646-649
Journal	European journal of nuclear medicine
Volume	28
Issue number	5
DOIs	https://doi.org/10.1007/s002590100513
Publication status	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s002590100513

Cite this

@article{506365ea1cea4c4fa476834158eab137,

title = "Summary of the Second International Sentinel Node Conference",

abstract = "A personal account is given of the most notable developments in lymphatic mapping that were discussed at the international conference {"}Sentinel Node 2000{"}, held in December 2000 in Santa Monica. The latest advances in tracers, imaging, instrumentation and radiation are first outlined. Thereafter, techniques, results and controversies with respect to melanoma, breast cancer and other cancers are discussed. It is concluded that lymphatic mapping is quickly gaining momentum. The technique that is best used for lymphatic mapping is well established in melanoma but not in breast cancer. The results of large randomised studies are awaited in both these diseases. Gastrointestinal cancer is the main new focus",

author = "Nieweg, \{O. E.\} and Tanis, \{P. J.\} and Rutgers, \{E. J.\}",

year = "2001",

doi = "10.1007/s002590100513",

language = "English",

volume = "28",

pages = "646--649",

journal = "European journal of nuclear medicine",

issn = "0340-6997",

publisher = "Springer Verlag",

number = "5",

}

TY - JOUR

T1 - Summary of the Second International Sentinel Node Conference

AU - Nieweg, O. E.

AU - Tanis, P. J.

AU - Rutgers, E. J.

PY - 2001

Y1 - 2001

N2 - A personal account is given of the most notable developments in lymphatic mapping that were discussed at the international conference "Sentinel Node 2000", held in December 2000 in Santa Monica. The latest advances in tracers, imaging, instrumentation and radiation are first outlined. Thereafter, techniques, results and controversies with respect to melanoma, breast cancer and other cancers are discussed. It is concluded that lymphatic mapping is quickly gaining momentum. The technique that is best used for lymphatic mapping is well established in melanoma but not in breast cancer. The results of large randomised studies are awaited in both these diseases. Gastrointestinal cancer is the main new focus

AB - A personal account is given of the most notable developments in lymphatic mapping that were discussed at the international conference "Sentinel Node 2000", held in December 2000 in Santa Monica. The latest advances in tracers, imaging, instrumentation and radiation are first outlined. Thereafter, techniques, results and controversies with respect to melanoma, breast cancer and other cancers are discussed. It is concluded that lymphatic mapping is quickly gaining momentum. The technique that is best used for lymphatic mapping is well established in melanoma but not in breast cancer. The results of large randomised studies are awaited in both these diseases. Gastrointestinal cancer is the main new focus

U2 - 10.1007/s002590100513

DO - 10.1007/s002590100513

M3 - Article

C2 - 11383872

SN - 0340-6997

VL - 28

SP - 646

EP - 649

JO - European journal of nuclear medicine

JF - European journal of nuclear medicine

IS - 5

ER -

Summary of the Second International Sentinel Node Conference

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this